1. Introduction {#sec1-ijerph-17-04139}
===============

The BRICS countries (i.e., Brazil, Russian Federation--called Russia hereafter, India, China, South Africa) are increasingly recognized as important players in global health and development \[[@B1-ijerph-17-04139],[@B2-ijerph-17-04139],[@B3-ijerph-17-04139],[@B4-ijerph-17-04139],[@B5-ijerph-17-04139],[@B6-ijerph-17-04139],[@B7-ijerph-17-04139],[@B8-ijerph-17-04139],[@B9-ijerph-17-04139]\]. Traditionally, the G7 (the group of the seven most powerful world economies) steered major health initiatives globally, through policies, priorities and developmental aid to support and improve health in Low-and Middle-Income Countries (LMICs) \[[@B1-ijerph-17-04139]\]. However, global health attention has been turning to the strategic role of emerging economies, especially the BRICS nations. These are the five large emerging economies that formalized a coalition and agenda for economic growth and health gains apart from the traditional, western global agenda \[[@B1-ijerph-17-04139],[@B2-ijerph-17-04139],[@B4-ijerph-17-04139],[@B5-ijerph-17-04139],[@B6-ijerph-17-04139],[@B7-ijerph-17-04139],[@B8-ijerph-17-04139],[@B9-ijerph-17-04139]\].

The BRICS countries, which formalized their coalition in 2006, generate 25% of the world's gross national income, have approximately 40% of the world's population, approximately 50% of the world's poor, and represent 40% of the global burden of disease \[[@B2-ijerph-17-04139]\]. Through strategic cooperation and inter-BRICS policies, the BRICS nations increasingly seek to translate their economic growths into improved population health \[[@B7-ijerph-17-04139],[@B10-ijerph-17-04139],[@B11-ijerph-17-04139]\]. Their health ministries have been met annually to discuss synergies, priorities and innovations tailored to their resource-constrained settings \[[@B7-ijerph-17-04139],[@B10-ijerph-17-04139]\]. The BRICS nations' agendas have been different than the Western nations, with a particular emphasis on social justice and equity in health in context of their unique, multifaceted health challenges \[[@B7-ijerph-17-04139],[@B10-ijerph-17-04139]\]. The BRICS' national health challenges include important increases in the prevalence of non-communicable, chronic diseases \[[@B3-ijerph-17-04139],[@B12-ijerph-17-04139],[@B13-ijerph-17-04139],[@B14-ijerph-17-04139],[@B15-ijerph-17-04139],[@B16-ijerph-17-04139],[@B17-ijerph-17-04139],[@B18-ijerph-17-04139]\] along with a still prevalent burden of communicable conditions \[[@B19-ijerph-17-04139],[@B20-ijerph-17-04139]\], multifaceted social determinants of health, and high inequalities in health and healthcare access \[[@B2-ijerph-17-04139],[@B21-ijerph-17-04139]\]. As these challenges are similar to those of other LMICs, advances in the BRICS health policies, cooperation, and healthcare delivery have been inspiring for other countries with developing economies \[[@B4-ijerph-17-04139],[@B6-ijerph-17-04139],[@B10-ijerph-17-04139]\]. Finally, the BRICS countries have been providing concrete assistance to the LMICs; \[[@B7-ijerph-17-04139],[@B8-ijerph-17-04139],[@B9-ijerph-17-04139]\] for example, through a "South-South Cooperation" over 55 years, China has dispatched medical teams, constructed facilities, distributed drugs and medical devices, and has trained local health workers in more than 66 countries in need \[[@B9-ijerph-17-04139]\].

Despite their economic developments and coalition, the BRICS countries face themselves a shortage of key health resources (e.g., health and allied health professionals) for their growing and complex health needs, in the context of many other societal demands \[[@B21-ijerph-17-04139],[@B22-ijerph-17-04139]\]. These needs accentuate the complexity of planning for equitable and effective health and social care amidst rapid demographic, economic and epidemiological transitioning \[[@B3-ijerph-17-04139],[@B12-ijerph-17-04139],[@B13-ijerph-17-04139],[@B14-ijerph-17-04139],[@B15-ijerph-17-04139],[@B16-ijerph-17-04139],[@B17-ijerph-17-04139],[@B18-ijerph-17-04139]\]. BRICS countries therefore had to be innovative to re-engineer the health and social care systems challenges (often limited healthcare finances, workforce, training, service planning and administration to address population healthcare needs), as well as the growing numbers of persons living with disability \[[@B23-ijerph-17-04139],[@B24-ijerph-17-04139],[@B25-ijerph-17-04139],[@B26-ijerph-17-04139]\].

Worldwide and especially in emerging economies, increasing numbers of people now live with functional limitations \[[@B1-ijerph-17-04139],[@B12-ijerph-17-04139],[@B26-ijerph-17-04139]\]. This can be explained from the demographic and epidemiological transitions with increasing life expectancy, an ageing population and the subsequent burden of chronic diseases \[[@B18-ijerph-17-04139],[@B26-ijerph-17-04139],[@B27-ijerph-17-04139],[@B28-ijerph-17-04139],[@B29-ijerph-17-04139],[@B30-ijerph-17-04139],[@B31-ijerph-17-04139]\]. Not only are many people now living with chronic communicable diseases which previously were fatal, but there is also an increasing prevalence of non-communicable diseases which are lifestyle-related and/or come as complex, multiple co-morbidities resulting in varying types and degrees of long-term disabilities \[[@B1-ijerph-17-04139],[@B13-ijerph-17-04139],[@B32-ijerph-17-04139],[@B33-ijerph-17-04139],[@B34-ijerph-17-04139],[@B35-ijerph-17-04139],[@B36-ijerph-17-04139],[@B37-ijerph-17-04139],[@B38-ijerph-17-04139],[@B39-ijerph-17-04139],[@B40-ijerph-17-04139],[@B41-ijerph-17-04139]\]. Rehabilitation is required to attenuate the effects of disability and optimize functioning in people with functional limitations from any health condition \[[@B25-ijerph-17-04139],[@B42-ijerph-17-04139]\]. Failure to address individuals' rehabilitation needs impacts on human functioning, social justice, human rights, productivity, long-term costs of care, and even could impact countries' economic growth \[[@B42-ijerph-17-04139],[@B43-ijerph-17-04139],[@B44-ijerph-17-04139],[@B45-ijerph-17-04139],[@B46-ijerph-17-04139]\].

In line with increasing disability prevalence, a recent study using data from Global Burden of Disease Study 2017 found a 17% increase in the world's physical rehabilitation needs per capita since 1990, and an almost twofold greater increase (29.9%) in upper-middle-income countries (UMICs), which include four of the BRICS countries (except India) \[[@B25-ijerph-17-04139]\]. The World Health Organization's (WHO) Rehabilitation 2030 initiative advocates for the inclusion of rehabilitation in universal health coverage, across countries of all income levels \[[@B42-ijerph-17-04139]\]. All BRICS countries have now committed to universal health coverage, although with varied levels of coverage, principles and roll-out over the next decade \[[@B6-ijerph-17-04139],[@B11-ijerph-17-04139],[@B22-ijerph-17-04139],[@B47-ijerph-17-04139]\]. It is therefore timely to determine the need for rehabilitation in BRICS countries. This information will not only support advocacy and strategic planning for the widespread inclusion of rehabilitation in the roll-out and expansion of universal health coverage in BRICS countries, but it will inform improvements in the planning for rehabilitation services in other LMICs.

This paper aims to analyze the current and evolving physical rehabilitation needs of the BRICS countries. The specific study questions are:(1)How large are the physical rehabilitation needs in 2017 for each BRICS country (e.g., in nominal values, population-adjusted rates, age-standardized rates), and how have those values evolved since 1990?(2)Which condition groups (e.g., musculoskeletal, neurological, cardiothoracic) account for the highest rates of physical rehabilitation need for each of the BRICS countries in 2017, and how have those values evolved since 1990?

2. Materials and Methods {#sec2-ijerph-17-04139}
========================

This paper refers to a secondary, cross-national comparative analysis of global epidemiological data in the public domain. To estimate the physical rehabilitation needs for each of the BRICS nations, we use data from the 2017 Global Burden of Disease Study (GBD) \[[@B48-ijerph-17-04139]\]. Specifically, we combine the methods of two recent papers using GBD data to analyzing global physical rehabilitation needs \[[@B25-ijerph-17-04139],[@B49-ijerph-17-04139]\]. The first uses GBD data to determining total physical rehabilitation needs, i.e., for all conditions relevant to physical rehabilitation combined \[[@B25-ijerph-17-04139]\]. The second stratifies these needs by condition type, e.g., musculoskeletal, neurological, cardiothoracic \[[@B49-ijerph-17-04139]\]. The use of those standard methods allows for the new findings for the BRCIS nations to be compared with the existing global benchmarks, i.e., physical rehabilitation needs for the world and for the groups of countries for all income levels \[[@B25-ijerph-17-04139],[@B49-ijerph-17-04139]\].

To determine the physical rehabilitation needs for the BRICS nations, we apply and combine the abovementioned standard methods as follows: In April 2019, public-domain data from the GBD 2017 were systematically extracted from a freely-available web platform: the Global Health Data Exchange tool (<http://ghdx.healthdata.org/gbd-results-tool>).

With the due measures to avoid double counting \[[@B25-ijerph-17-04139]\], data were extracted for the set of health conditions likely benefiting from physical rehabilitation. Previously, these were systematically determined and tested for robustness (i.e., similar patterns of results were found for a sub-set of conditions) \[[@B25-ijerph-17-04139]\]. [Table 1](#ijerph-17-04139-t001){ref-type="table"}, left column, details the set of conditions deemed as likely benefiting from physical rehabilitation.

Among the GBD "measures", we extract data only for Years Lived with Disability (YLDs), due its exclusive focus on non-fatal health losses. YLDs consist of the years lived with any short-term or long-term health loss weighted for severity by disability weights. For stroke, for example, disability weights vary from 0.019 for mild consequences to 0.588 for severe consequences plus cognition problems. Details on how YLDs and disability weights are determined, and the disability weights for all conditions, are available elsewhere \[[@B48-ijerph-17-04139],[@B50-ijerph-17-04139]\].

For "years", data were extracted for every year between 1990 and 2017, for a more precise determination of the evolving trend. For "location", YLDs were extracted at the national level for each of the BRICS. No sub-national data were extracted, as we focused on nation-wide and cross-national analyses.

As for "metrics", we extracted YLDs data for prevalent *number* (i.e., YLD counts), *rate* (i.e., YLDs per 100,000 people), and *percentage* (i.e., percentage of YLDs from the selected conditions relative to the total amount of YLDs).

Regarding "age", we extracted YLDs both for *all ages* and *age-standardized* rates, the latter used to determine *age-standardized YLD Rates* (i.e., physical rehabilitation needs adjusted for both population size and ageing).

All the selected data were imported from the webtool to Excel spreadsheets for data storage, management, and analysis.

In the Excel spreadsheets, we summed YLDs within each of the five "locations", four "metrics", and 28 "years", computed any percent changes from 1990 to 2017, plotted the entire time series \[1990--2017\] of the combined YLD values, and then determined which type of simple regression model (i.e., linear, exponential, or logarithmic) best fit the plotted data. We used visualization and *r*^2^ values for that. Given negligible differences in *r*^2^ values (\<0.02 between the models), we retained the linear regression option.

To assess yearly changes of YLDs between 1990 and 2017, ANOVA was applied. This test considers the data on every year between 1990 and 2017, which increases preciseness. The significance level for the analysis was set at two subsequent levels: *p* = 0.05 and *p* = 0.01, the latter accounts for a Bonferroni correction (0.05/5 = 0.01) considering the analyses are made for five countries within each item/metric under study. The respective confidence intervals (CIs) in turn were used to analyze whether yearly changes for each BRICS nation significantly differed (i.e., did not overlap) from those of the 4 other BRICS countries or from the global benchmarks that we extracted from the literature--as the same methods were used \[[@B25-ijerph-17-04139],[@B49-ijerph-17-04139]\].

Finally, using the analytical procedures above, we performed a subgroup analysis on the physical rehabilitation needs, stratified per six major groups of conditions--detailed in the [Table 1](#ijerph-17-04139-t001){ref-type="table"}′s right column. For that analysis, we only use *YLD Rates* as a metric, either through actual *YLD Rates* or through those transformed into percent values, e.g., percentage of the YLD Rates related to physical rehabilitation that came specifically from neurological conditions.

3. Results {#sec3-ijerph-17-04139}
==========

We provide below the results for the two study questions:

3.1. Total Physical Rehabilitation Needs {#sec3dot1-ijerph-17-04139}
----------------------------------------

[Table 2](#ijerph-17-04139-t002){ref-type="table"} shows a significant increase in total physical rehabilitation needs from 1990 to 2017 across the five countries in all the metrics analyzed (*p* \< 0.01); the exception being Age-Standardized YLD Rates for both India and Russia, with no significant changes since 1990 (*p* \> 0.05).

Per metric, [Table 2](#ijerph-17-04139-t002){ref-type="table"} (see [Supplementary Material 1](#app1-ijerph-17-04139){ref-type="app"}, pages 1 to 4, for a visual representation of the data) shows the following trends:

In YLD Counts (i.e., absolute YLD values), South Africa more than doubled their physical rehabilitation needs from 1990 to 2017 (i.e., 114.1% growth), similarly to low-income countries (i.e., 111.5% growth). India, Brazil, and China had a 91.6%, 82.6%, and 68.1% growth, respectively. Russia, in turn, had the lowest percentage growth in YLD counts (7.6%), substantially lower than any global benchmark: i.e., the lowest being 37.4% for high-income countries.

In YLD Rates (i.e., YLDs per 100,000 people), Russia had the highest value in 2017 (6393), but South Africa and China had the highest yearly growths (99% CIs: 56.8−90.0 and 47.6−60.9, respectively), each of them significantly higher (i.e., greater, non-overlapping 99% CIs) than those of the 3 other BRICS nations or any global benchmark.

In Age-standardized YLD Rates, (i.e., YLDs adjusted for both population size and ageing), South Africa had the highest value in 2017 (5131), and significantly greater yearly increases (i.e., non-overlapping 99% CIs) than all comparators; for example high-income countries had a significant decrease. Russia and India had non-significant yearly changes in this metric.

Finally, in the percentage of YLDs likely benefiting from physical rehabilitation among total YLDs, Brazil stands out with nearly two-thirds of their YLDs coming from rehabilitation-sensitive conditions in 2017 (66.2%). For the other BRICS countries or global benchmarks, values were all below 50%; in India little more than one-third (35.9%). In South Africa, the yearly growths in the YLDs percentage were significantly greater while in Russia significantly lower than in any other BRICS nations. Indeed, the 99% CIs of the Russia's yearly growth was rather aligned (i.e., partly overlapping) with that of high-income nations.

3.2. Needs by Condition Types {#sec3dot2-ijerph-17-04139}
-----------------------------

[Table 3](#ijerph-17-04139-t003){ref-type="table"} (see [Supplementary Material 2](#app1-ijerph-17-04139){ref-type="app"}, pages 1 to 6, for a visual representation of the data) shows significant increases in rehabilitation-sensitive *YLD Rates* from 1990 to 2017 across the BRICS countries, for all the condition groups (*p* \< 0.01). The exceptions are the South African's YLD rates coming from pediatric and from neoplasm conditions (99% CIs: −1.60−1.53 and −0.06−0.62, respectively), although the latter had a significant increase within the 95% CI (0.03−0.53).

The highest yearly increases in *YLD Rates* came from: (1) HIV-related conditions in South Africa (*b* = 63.8), yet with a logarithmic growth (i.e., greater growth rate in the earlier years); (2) musculoskeletal & pain conditions in both Brazil and China (*b* = 25.4 and *b* = 25.0, respectively); (3) neurological conditions in China (*b* = 15.6), within exponential type of growth (i.e., greater growth rate in the more recent years), and (4) pediatric conditions in India (*b* = 7.18). In each of these cases, the growths were significantly greater (i.e., higher, non-overlapping 95% CIs) than those of any comparators for the same condition group. Finally, Russia stands out with the highest YLD Rates for neurological conditions in 2017, e.g., over than 3 times that of Brazil, India, or South Africa.

[Figure 1](#ijerph-17-04139-f001){ref-type="fig"} shows that Musculoskeletal & Pain conditions contributed the most to physical rehabilitation needs in 2017 across the five countries, ranging from 36% of South African's physical rehabilitation needs to 60% of Brazilian's - greater than any global benchmark. In India and Brazil, cardiothoracic conditions were the second most represented (22% and 16%, respectively). In China, both neurological and cardiothoracic conditions hold that second rank (18% each). In Russia, neurological conditions were the second most represented (19%). Finally, in South Africa, HIV-related conditions were the second most representative (25%): in no other BRICS country did HIV-related conditions accounted for more than 1% of physical rehabilitation needs, and the maximum global benchmark was 6% for low-income countries.

Finally, [Table 4](#ijerph-17-04139-t004){ref-type="table"} shows how the distribution of physical rehabilitation needs evolved per condition groups from 1990 to 2017. In South Africa, physical rehabilitation needs coming from HIV-related conditions increased massively, yet logarithmically: from 1% to 25% of South African's physical rehabilitation needs (*p* \< 0.01). In China, the percentage of physical rehabilitation needs coming from both neurological conditions and neoplasms increased significantly (from 12.3% to 18.4%, and from 1.42% to 2.86%, respectively: *p* \< 0.01), both with an exponential type of growth. In India, the percentage of physical rehabilitation needs coming from pediatric conditions increased significantly (from 15.7% to 17.8%: *p* \< 0.01). In Russia, the percentage of physical rehabilitation needs that came from neoplasms has grown by 47% (*p* \< 0.01). Finally, only in Brazil did the percentage of physical rehabilitation needs coming from musculoskeletal & pain conditions increased significantly (from 57.5% to 59.9%; *p* \< 0.01), becoming greater than that in high-income countries (57.7% in 2017).

4. Discussion {#sec4-ijerph-17-04139}
=============

In each of the BRICS countries, total physical rehabilitation needs have increased significantly from 1990 to 2017 in absolute values, per-capita, and in percentage of all YLDs. This means that, in each of these countries, physical rehabilitation needs have increased beyond the population growth, and that physical rehabilitation could be helpful for a greater portion of non-fatal health losses.

Apart from common trends across the BRICS nations (e.g., growth of total physical rehabilitation needs per capita with no decrease or even an increase in age-standardized needs), we found important country-specific differences across the BRICS countries in the amount, typology, and evolution of their physical rehabilitation needs.

For the overall age-standardized YLD Rates germane to physical rehabilitation, we did not observe significant changes for India and Russia. This means that for these countries the aging of the population (and the subsequent higher disability rates \[[@B23-ijerph-17-04139],[@B26-ijerph-17-04139],[@B28-ijerph-17-04139]\]) has been a key driver of their increased physical rehabilitation needs, including in YLDs Rates. Yet, in Brazil, China, and South Africa we did observe a significant growth in the age-standardized YLD Rates, which means that variables other than those related to the population ageing might have contributed to the overall growth of their physical rehabilitation needs. Only in high-income nations did we observe a significant decrease in the rehabilitation-related age-standardized YLD Rates. Possibly a more developed rehabilitation infrastructure or health care systems in high-income nations than in the BRICS nations contributed their reduction in age-standardized YLD-rates for rehabilitation-related conditions.

China stood out with the greatest amount and an exponential type of growth in the physical rehabilitation needs from neurological and neoplasm conditions. The population ageing, derived from the previous one-child policy, increased life expectancy \[[@B30-ijerph-17-04139]\], increasing survival rates for those with neoplasm or other health conditions, along with the huge baby boom cohorts born in 1950s and 1960s entering old ages \[[@B39-ijerph-17-04139],[@B40-ijerph-17-04139],[@B51-ijerph-17-04139]\], can partly account for these findings. As survival rates from health conditions likely will increase further \[[@B52-ijerph-17-04139]\] and life expectancy in China is projected to surpass 80 years by 2040 \[[@B53-ijerph-17-04139]\], the rise of physical rehabilitation needs in China being observed is likely to continue into the future. Moreover, the meeting the rehabilitation needs of older adults in the rural, underserved regions of China can be particularly challenging as rehabilitation services typically are distant and/or scant and family support is increasingly absent (e.g., much of the working-age population has moved to urban, industrialized areas) \[[@B24-ijerph-17-04139]\]. Caregiver-delivered, digital-supported, and nurse-led interventions have been trialed to close the rehabilitation service gap in rural China, but more work is needed to achieve optimal results \[[@B54-ijerph-17-04139]\]. These will be important needs and gaps for China to address through future research and policy development \[[@B24-ijerph-17-04139],[@B51-ijerph-17-04139],[@B54-ijerph-17-04139],[@B55-ijerph-17-04139]\].

In India, another highly populated and emerging economy in Asia, the typology of physical rehabilitation needs was different than for the other BRICS nations and, in some respects, closer to that of lower income countries. One such example is the absolute and relative growth of physical rehabilitation needs arising from pediatric conditions. This pattern may reflect different economic status from the other BRICS: i.e., although an emergent economy, India is still a lower-middle income nation per the World Bank classification while the BRICS counterparts are UMICs. Alternatively, the findings may reflect a different population ageing structure and higher fertility rates \[[@B31-ijerph-17-04139]\]. In addition to the particular rise of pediatric physical rehabilitation needs in India, YLD Rates increased for each other major groups of conditions responsive to physical rehabilitation. Indeed, the epidemiological transition for higher rates of non-communicable, chronic and disabling conditions has been impacting India, although differentially across regions \[[@B13-ijerph-17-04139],[@B56-ijerph-17-04139],[@B57-ijerph-17-04139],[@B58-ijerph-17-04139]\]. All these needs contrast with the existing systems for rehabilitation and social care in the country. There is an acute shortage of 6.4 million allied health professionals in India \[[@B59-ijerph-17-04139]\]. There are no professional bodies that regulate the practice or practice standards for any health professionals \[[@B60-ijerph-17-04139]\]. The national program for tracking of non-communicable health conditions focuses on early detection and treatment \[[@B61-ijerph-17-04139]\]. Furthermore, the health system's infrastructure is not architecturally and socially accessible to people with disabilities \[[@B62-ijerph-17-04139]\]. Overall, the health system has not been capable of meeting the growing need for physical rehabilitation in India \[[@B58-ijerph-17-04139],[@B63-ijerph-17-04139]\]. Similar to China, technologically-enabled service delivery solutions have been trialed to meet the growing physical rehabilitation needs in India \[[@B64-ijerph-17-04139]\]. Interventions like these needs to be tested for scalability in combination with existing health and rehabilitation services in India.

South Africa, a leading UMIC within the African continent, more than doubled their absolute physical rehabilitation needs, mimicking the trend in low-income countries. This increase in need for rehabilitation is partly driven by the HIV/AIDS endemic. HIV-related conditions accounted for one-quarter of South African's physical rehabilitation needs in 2017, compared to 1% in any of the four other BRICS countries. South Africa's successful roll-out of highly active antiretroviral therapy (HAART) has transformed HIV into a chronic disease, and people with HIV can now achieve normal life-expectancy \[[@B65-ijerph-17-04139]\]. An increasing number of South Africans with HIV live longer, but with either the potential for or already established impairments in body structure such as muscle weakness, and that may cause limitations in activities of daily living and restrictions in participation \[[@B65-ijerph-17-04139]\]. Despite this, South Africa's HIV policies and guidelines do not speak to HIV-related disabilities, as premature mortality remains a key national health indicator \[[@B66-ijerph-17-04139]\]. However, political will to address non-fatal health loss is rising \[[@B67-ijerph-17-04139]\] as an increasing body of literature signals the need to address HIV-related disability \[[@B68-ijerph-17-04139],[@B69-ijerph-17-04139],[@B70-ijerph-17-04139]\]. Increased investment in health resources to enhance the quality of life and functioning in people with HIV will require concerted effort. Access to adequate rehabilitation has the potential to optimize functioning, employability and could even enhance HAART adherence in people living with HIV \[[@B70-ijerph-17-04139]\].

Russia had the highest rate of physical rehabilitation needs in 2017 (6393 YLDs per 100,000 inhabitants), but the lowest percent change since 1990; a pattern closest to that of high-income countries more than other BRICS nations. Similarly, we found that Russia had the highest rates, although not the highest growth, in physical rehabilitation needs from neurological conditions, including about the triple of those from Brazil, India and South Africa. The persistently high burden of rehabilitation-sensitive conditions in Russia may be a result of several factors. First, the incidence of major chronic non-communicable diseases remains high; national statistics have shown, for example, that the incidence of coronary heart disease has increased substantially from 495 to 701 per 100,000 inhabitants from 2010 to 2016 \[[@B71-ijerph-17-04139]\]. That accounts for the high prevalence of risk factors, primarily of hypertension and overweight/obesity, which is on the rise, especially in men \[[@B72-ijerph-17-04139]\]. In contrast, the rates of smoking and harmful alcohol use are currently decreasing \[[@B73-ijerph-17-04139]\], although historically high \[[@B14-ijerph-17-04139]\]. Secondly, the overall quality of healthcare has increased in Russia, resulting in increased survival; for example, the age-standardized mortality rates from myocardial infarction decreased from 47.1 to 42.9 per 100,000 inhabitants \[2012--2016\] \[[@B74-ijerph-17-04139]\]. Thirdly, higher survival rates may also arise from screening and early diagnosis programs such as the national universal health screening program for cancers and government-led program for screening cardiovascular risk factors and diseases \[[@B75-ijerph-17-04139]\]. Fourthly, local traditions of ICD 10 codes interpretation may lead to inappropriate coding of some dementia cases as cardiovascular or neurologic conditions instead of mental disorders \[[@B76-ijerph-17-04139]\]. Finally, the population has aged in Russia, which is not surprising given the growing per capita income in recent years, and the population aging seen in high-income countries \[[@B77-ijerph-17-04139]\]. Relatedly, the westernization of lifestyle in Russia, with a greater availability of highly processed foods and environmental problems due to increased car traffic, likely is playing in rendering physical rehabilitation needs in Russia similar to those high-income nations. To help meet their nation's high physical rehabilitation needs, Russia has been actively developing their medical rehabilitation paradigm \[[@B78-ijerph-17-04139]\] and infrastructure \[[@B79-ijerph-17-04139],[@B80-ijerph-17-04139]\].

Finally, for Brazil, we found that conditions responsive to physical rehabilitation currently account for about two-thirds of the nation's YLD (no other BRICS nation came close to 50%). This means that physical rehabilitation can address a larger portion of the country's non-fatal health losses when compared to the BRICS counterparts. Brazil also stood out with the highest portion of physical rehabilitation needs coming from musculoskeletal & pain conditions (60%), and with substantial growth in this percent value over time. Key explanations for that finding may include the prevalence of interpersonal violence in Brazil \[[@B16-ijerph-17-04139]\], and the high and rising prevalence of road traffic injuries, especially associated with high consumption of alcohol involving young pedestrian and motorcyclists within urbanized environments \[[@B81-ijerph-17-04139],[@B82-ijerph-17-04139]\]. This study emphasizes not only the need of expanding Brazilian public policies to ameliorate external causes of injury as well as chronic disease prevention, but also for implementing a rehabilitation infrastructure capable of addressing the growing burden of physical impairments in Brazil.

Study Limitations
-----------------

This study has the following limitations:First, YLDs from selected health conditions are but proxy indicators of physical rehabilitation needs, i.e., not a direct functional or impairments-based measure. Nonetheless, YLDs is the aggregative measure of non-fatal health loss from the prominent GBD study and includes variables such as the prevalence of conditions, the time lived with sequalae from the respective conditions, and weighted for the appraised severity of those sequelae.Second, the set of conditions whose YLDs likely benefit from rehabilitation were replicated from a previous study which systematically reviewed evidence linking those conditions to rehabilitation needs; \[[@B25-ijerph-17-04139]\] nonetheless, these conditions cannot be considered a fixed standard as the relevant conditions may change over time with the advancement of rehabilitation therapies and their scientific support. For example, the recent COVID-19 pandemic has been boosting new types of rehabilitation need (e.g., for respiratory therapy; for the rehabilitation for the post-intensive care syndrome) \[[@B83-ijerph-17-04139],[@B84-ijerph-17-04139],[@B85-ijerph-17-04139]\], which were not reflected in the data up to 2017.Third, YLD values (extracted from the GBD 2017) are only estimates based on the best-available evidence, not actual YLDs. The GBD 2017 is the most comprehensive epidemiological study to date, and the amount of data used to create those estimates is unprecedented \[[@B25-ijerph-17-04139],[@B48-ijerph-17-04139]\]. Even so, the quality and the quantity of the underlying data for computing the GBD estimates vary across locations and in time within the same location, which in turn affects the precision of the YLD estimates. However, lower precision does not equate to bias toward over or under-estimation of YLDs for the earlier times or for the locations in which less or lower-quality data were available. At each cycle, the GBD study (e.g., the GBD 2017) apply the new data and more advanced estimation methods to re-calculate YLDs across locations and the entire time series (since 1990), not only the values for 2017.Fourth, most data obtained for the GBD study (e.g., in India) are from self-reports and hence many undiagnosed conditions might not be included within this data to represent the true picture. Hence results of this study could be a gross under-estimation of the problem, at least in the absolute values.Fifth, we did not extract or analyze sub-national data (e.g., Brazilian states), although data are available for that from the GBD 2017 and some important differences exist in both economic and epidemiological profiles across regions or states of the analyzed countries \[[@B13-ijerph-17-04139],[@B16-ijerph-17-04139],[@B39-ijerph-17-04139]\].Sixth, we do not supplement our analyses of physical rehabilitation 'needs' with indicators of physical rehabilitation 'supply' across nations, the other key element in the resources planning equation. In part, this follows the lack of available data. For example, the World Confederation of Physical Therapy reports data on the amount of practicing physical therapists per nations, as locally collected from authoritative sources or estimated by national associations (i.e., their member organizations) for a total of 89 countries, but unfortunately not from 3 of the analyzed countries (China, Russia, or India) \[[@B86-ijerph-17-04139]\].

5. Conclusions {#sec5-ijerph-17-04139}
==============

Physical rehabilitation needs have increased significantly from 1990 to 2017 in each of the BRICS nations, both in absolute and relative values. However, apart from the common trend in overall growth, each of the BRICS nations had own patterns for the amount, typology, and evolution of their physical rehabilitation needs. The BRICS nations and coalition need to address the common challenge of planning for and deploying the required resources for meeting the growing physical rehabilitation needs of their population, at the same time they look at country-specific challenges such as the physical rehabilitation needs coming from HIV/AIDs-related conditions in South Africa, pediatric conditions in India, musculoskeletal conditions in Brazil, and neurological conditions in Russia and China. This study shows that physical rehabilitation needs can be determined and compared across nations, and hence can be used to inform rehabilitation resources and service planning. Most importantly, this study makes clear that physical rehabilitation needs and growth patterns may not be assumed equal across nations, irrespective of similarities in income or emerging development.

Not applicable.

The following are available online at <https://www.mdpi.com/1660-4601/17/11/4139/s1>. Supplementary Material 1: Total Physical Rehabilitation Needs. Supplementary Material 2: Needs by condition type.
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###### 

How Years Lived with Disability from health conditions of the Global Burden of Disease Study 2017 are grouped, referring to type of impairments or type physical rehabilitation service level. Due to its specificity, we do not aggregated YLDs from neoplasm and HIV/AIDS.

  Underlying Health Conditions (from the Global Burden of Disease Study)                                                                                 Intermediate Aggregation                    Main Groups (Condition Types)
  ------------------------------------------------------------------------------------------------------------------------------------------------------ ------------------------------------------- -------------------------------
  Low back pain                                                                                                                                          Pain                                        Musculoskeletal & Pain
  Neck pain                                                                                                                                                                                          
  Tension-type headaches                                                                                                                                                                             
  Injuries (all selected except Spinal & Brain Injuries; Asphyxiation; and Severe Chest Injuries)                                                        Musculoskeletal Trauma                      
  Osteoarthritis                                                                                                                                         Musculoskeletal disorders                   
  Rheumatoid arthritis                                                                                                                                                                               
  Gout & Other musculoskeletal disorders                                                                                                                                                             
  Leprosy                                                                                                                                                                                            
  Chronic Respiratory Diseases                                                                                                                           Pulmonary                                   
  Severe Chest Injuries                                                                                                                                                                              
  Cardiovascular Diseases (excluding Stroke)                                                                                                             Cardiovascular                              Cardiotoracic
  Heart Failure (resulting from all the non-considered health conditions)                                                                                                                            
  Stroke                                                                                                                                                 Neurological Disorders (non-communicable)   Neurological
  Multiple sclerosis; Parkinson's; Alzheimer's & Other Dementias; Motor neuron disease; Other neurological disorders; Neoplasm--brain & nervous system                                               
  Infectious--affecting the nervous system: Encephalitis; Meningitis; Tetanus; ZIKA virus                                                                Neurological--Infectious \*                 
  Syndrome: Guillain-Barré (resulting from non-considered health conditions)                                                                                                                         
  Spinal Cord Injury                                                                                                                                     Neurological Trauma                         
  Traumatic Brain Injury; Asphyxiation                                                                                                                                                               
  Congenital birth defects (*digestive & urogenital disorders excluded*)                                                                                 \-                                          Pediatric \*\*
  Neonatal                                                                                                                                                                                           
  Autism Spectrum Disorder                                                                                                                                                                           
  All Neoplasms (not nervous system)                                                                                                                     \-                                          Neoplasm (not nervous system)
  HIV/AIDS                                                                                                                                               \-                                          HIV-related

Legend: \* Conditions that may have early onsets and hence rather require *pediatric* physical rehabilitation. Zika virus can led to both neurological and musculoskeletal sequalae and physical rehabilitation interventions. \*\* When leading to long-term impairments, *pediatric* conditions may also require adult physical rehabilitation services.
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###### 

YLDs (Years Lived with Disability), in four metrics, from all conditions likely benefiting from physical rehabilitation--i.e., all conditions combined. YLD values are provided for each of the five countries analyzed, as well as for global benchmarks.

                                                                             1990      2017      \% Change \[1990--2017\]   Regression Model Type   *r* ^2^   *b* Coefficient   95% CI             99% CI
  -------------------------------------------------------------------------- --------- --------- -------------------------- ----------------------- --------- ----------------- ------------------ ------------------
  **YLD Counts, Millions**                                                                                                                                                                         
  Brazil                                                                     4.94      9.02      82.6%                      Linear                  1         0.16 \*           0.15--0.16         0.15--0.16
  China                                                                      39.8      67.0      68.1%                      Linear                  0.98      1.01 \*           0.94--1.07         0.92--1.10
  India                                                                      28.8      55.1      91.6%                      Linear                  0.98      0.98 \*           0.93--1.03         0.91--1.05
  Russia                                                                     8.69      9.35      7.6%                       Linear                  0.76      0.03 \*           0.02--0.04         0.02--0.04
  South Africa                                                               1.25      2.68      114.1%                     Linear                  0.94      0.06 \*           0.06--0.07         0.05--0.07
  *World*                                                                    *206.4*   *342.9*   *66.2%*                    *Linear*                *0.99*    *5.10 \**         *4.88--5.32*       *4.80--5.40*
  *High-income*                                                              *57.5*    *79.0*    *37.4%*                    *Linear*                *0.99*    *0.81 \**         *0.77--0.84*       *0.76--0.86*
  *Upper Middle-Income*                                                      *75.9*    *123.0*   *62.1%*                    *Linear*                *0.99*    *1.78 \**         *1.69--1.87*       *1.66--1.90*
  *Lower Middle-Income*                                                      *62.3*    *118.8*   *90.4%*                    *Linear*                *0.99*    *2.10 \**         *2.02--2.19*       *1.99--2.22*
  *Low-Income*                                                               *9.81*    *20.8*    *111.5%*                   *Linear*                *1*       *0.39 \**         *0.38--0.40*       *0.38--0.41*
  **YLD Rates (per 100,000 inhabitants)**                                                                                                                                                          
  Brazil                                                                     3306      4528      28.8%                      Linear                  1         37.2 \*           36.3--38.1         36.0--38.4
  China                                                                      3329      4743      42.5%                      Linear                  0.95      54.3 \*           49.3--59.2         47.6--60.9
  India                                                                      3300      3990      20.9%                      Linear                  0.92      25.2 \*           22.2--28.2         21.1--29.3
  Russia                                                                     5741      6393      11.4%                      Linear                  0.91      31.6 \*           27.6--35.6         26.2--37.0
  South Africa                                                               3399      4803      43.3%                      Linear                  0.85      73.4 \*           61.1--85.7         56.8--90.0
  World                                                                      *3825*    *4488*    *17.3%*                    *Linear*                *0.96*    *25.7 \**         *23.7--27.7*       *23.0--28.4*
  *High-income*                                                              *5748*    *6643*    *15.6%*                    *Linear*                *0.98*    *33.1 \**         *31.1--35.1*       *30.4--35.8*
  *Upper Middle-Income*                                                      *3594*    *4669*    *29.9%*                    *Linear*                *0.96*    *42.6 \**         *39.3--46.0*       *38.1--47.2*
  *Lower Middle-Income*                                                      *3233*    *3806*    *17.7%*                    *Linear*                *0.96*    *21.6 \**         *19.9--23.2*       *19.3--23.8*
  *Low-Income*                                                               *2977*    *3112*    *4.5%*                     *Logarithmic*           *0.50*    *2.5 \*\**        *0.40--4.55*       *−0.33--5.28*
  **Age-standardized YLD Rates**                                                                                                                                                                   
  Brazil                                                                     3993      4010      0.44%                      Linear                  0.69      2.9 \*            2.08--3.63         1.81--3.90
  China                                                                      3795      3898      2.71%                      Linear                  0.24      5.4 \*            1.47--9.02         0.14--10.4
  India                                                                      4361      4368      0.16%                      Logarithmic             0.09      \- 0.2            −2.62--2.22        −3.47--3.08
  Russia                                                                     5156      4991      −3.20%                     Logarithmic             0.13      \- 0.1            −4.02--3.77        −5.40--5.14
  South Africa                                                               4415      5131      16.2%                      Logarithmic             0.72      47.8 \*           32.7--62.8         27.5--68.1
  *World*                                                                    *4377*    *4334*    *−1.0%*                    *Logarithmic*           *0.22*    *−0.62*           *−2.13--0.89*      *−2.66--1.42*
  *High-income*                                                              *5007*    *4872*    *−2.7%*                    *Logarithmic*           *0.86*    *−5.36 \**        *−6.76--(−3.96)*   *−7.26--(−3.47)*
  *Upper Middle-Income*                                                      *4106*    *4080*    *−0.6%*                    *Linear*                *0.04*    *1.34*            *−1.38--4.06*      *−2.33--5.02*
  *Lower Middle-Income*                                                      *4262*    *4314*    *1.2%*                     *Linear*                *0.46*    *2.33 \**         *1.26--3.40*       *0.89--3.78*
  *Low-Income*                                                               *4189*    *4276*    *2.1%*                     *Logarithmic*           *0.15*    *0.29*            *−3.29--3.87*      *−4.55--5.14*
  **% of YLDs Benefiting from Physical Rehabilitation (among total YLDs)**                                                                                                                         
  Brazil                                                                     60.1%     66.2%     10.2%                      Linear                  0.96      0.26 \*           0.24--0.28         0.23--0.29
  China                                                                      37.8%     44.8%     18.7%                      Linear                  0.97      0.26 \*           0.24--0.28         0.24--0.29
  India                                                                      29.9%     35.9%     20.1%                      Linear                  0.93      0.23 \*           0.21--0.26         0.20--0.27
  Russia                                                                     45.4%     46.6%     2.6%                       Linear                  0.46      0.07 \*           0.04--0.09         0.03--0.11
  South Africa                                                               34.8%     43.8%     25.8%                      Linear                  0.87      0.43 \*           0.37--0.50         0.34--0.52
  *World*                                                                    *36.7%*   *40.2%*   *9.5%*                     *Linear*                *0.97*    *0.14 \**         *0.13--0.15*       *0.12--0.15*
  *High-income*                                                              *47.6%*   *48.6%*   *2.2%*                     *Linear*                *0.87*    *0.03 \**         *0.03--0.04*       *0.02--0.04*
  *Upper Middle-Income*                                                      *37.9%*   *42.2%*   *11.4%*                    *Linear*                *.97*     *0.17 \**         *0.16--0.18*       *0.15--0.19*
  *Lower Middle-Income*                                                      *30.7%*   *35.9%*   *16.8%*                    *Linear*                *0.98*    *0.20 \**         *0.19--0.21*       *0.19--0.22*
  *Low-Income*                                                               *27.8%*   *32.1%*   *15.4%*                    *Linear*                *0.97*    *0.16 \**         *0.15--0.17*       *0.14--0.17*

Data obtained from: <http://ghdx.healthdata.org/gbd-results-tool>. Abbreviations: YLD--Year Lived with Disability. Legend: \* *p* \< 0.01; \*\* *p* \< 0.05. While possibly obtained through the same source, data for the global benchmarks, including computed values, were extracted from: Jesus TS, Landry MD, Hoenig H. Global need for physical rehabilitation: systematic analysis from the Global Burden of Disease Study 2017. *Int J Environ Res Public Health*. 2019, 16: 980; Notes: The "*b* coefficient" refers to the annual change within a linear regression model. Different population structures apply to countries with varying income levels; so, cross-location comparisons are not valid for the metric YLD Counts, except for the variable "% change \[1990--2017".
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###### 

How YLD Rates (i.e., Years Lived with Disability per 100,000 people) likely benefiting from physical rehabilitation are distributed per major groups of conditions across the five countries analyzed, and how values have evolved over time \[1990--2017\].

                               1990     2017     \% Change \[1990--2017\]   Regression Model Type   r^2^     b Coefficient   95% CI          99% CI
  ---------------------------- -------- -------- -------------------------- ----------------------- -------- --------------- --------------- ---------------
  **Musculoskeletal & Pain**                                                                                                                 
  Brazil                       1901     2551     34.2%                      Linear                  1        25.4 \*         24.9--25.9      24.8--26.0
  China                        1646     2258     37.2%                      Linear                  0.99     25.0 \*         23.8--26.2      23.4--26.6
  India                        1765     2048     16.0%                      Linear                  0.91     10.1 \*         8.9--11.4       8.4--11.9
  Russia                       3271     3435     5.0%                       Linear                  0.88     11.6 \*         9.8--13.3       9.2--13.9
  South Africa                 1605     1731     7.9%                       Linear                  0.93     5.7 \*          5.1--6.4        4.9--6.6
  *World*                      *2071*   *2363*   *14.1%*                    *Linear*                *0.98*   *11.4 \**       *10.7−12.1*     *10.5−12.4*
  *High-Income*                *3359*   *3835*   *14.2%*                    *Linear*                *0.99*   *16.8 \**       *16.1−17.5*     *15.9−17.7*
  *Upper Middle-Income*        *1875*   *2369*   *26.3%*                    *Linear*                *0.98*   *20.5 \**       *19.4−21.5*     *19.0−21.9*
  *Lower Middle-Income*        *1724*   *1983*   *15.1%*                    *Linear*                *0.96*   *9.4 \**        *8.6−10.3*      *8.3−10.5*
  *Low-Income*                 *1486*   *1491*   *0.4%*                     *Linear*                *0.09*   *−0.6*          *−1.3−0.1*      *−1.5−0.4*
  **Neurological**                                                                                                                           
  Brazil                       263      396      50.4%                      Linear                  0.96     5.2 \*          4.7--5.6        4.6--5.7
  China                        410      870      112.5%                     Exponential             0.97     15.6 \*         13.8--17.3      13.2--17.9
  India                        247      323      30.5%                      Linear                  0.94     2.8 \*          2.5--3.1        2.4--3.2
  Russia                       922      1207     30.9%                      Linear                  0.83     11.4 \*         9.3--13.4       8.6--14.1
  South Africa                 330      356      7.9%                       Linear                  0.57     0.7 \*          0.5--1.0        0.4--1.1
  *World*                      *441*    *578*    *31.1%*                    *Linear*                *0.89*   *4.8 \**        *4.1−5.5*       *3.9−5.7*
  *High-Income*                *750*    *929*    *23.7%*                    *Linear*                *0.90*   *6.1 \**        *5.3−6.9*       *5.0−7.2*
  *Upper Middle-Income*        *441*    *736*    *66.9%*                    *Exponential*           *0.95*   *10.4 \**       *9.1−11.6*      *8.7−12.0*
  *Lower Middle-Income*        *301*    *364*    *21.2%*                    *Linear*                *0.86*   *2.3 \**        *1.9−2.7*       *1.8−2.8*
  *Low-Income*                 *321*    *314*    *−2.1%*                    *Linear*                *0.53*   *−0.5 \**       *−0.7−(−0.3)*   *−0.8−(−0.2)*
  **Cardiotoracic**                                                                                                                          
  Brazil                       624      685      9.8%                       Linear                  0.88     2.65 \*         2.3--3.1        2.11--3.19
  China                        759      857      12.9%                      Linear                  0.36     4.95 \*         2.3--7.6        1.35--8.56
  India                        746      857      14.8%                      Linear                  0.49     4.02 \*         2.4--5.7        1.78--6.26
  Russia                       802      856      6.7%                       Linear                  0.94     2.21 \*         2.0--2.4        1.90--2.52
  South Africa                 851      918      7.9%                       Logarithmic             0.73     2.89 \*         1.7--4.1        1.23--4.56
  *World*                      *733*    *807*    *10.1%*                    *Linear*                *0.63*   *3.5 \**        *2.4−4.5*       *2.0−4.9*
  *High-Income*                *956*    *1103*   *15.4%*                    *Linear*                *0.94*   *7.0 \**        *6.3−7.7*       *6.0−8.0*
  *Upper Middle-Income*        *719*    *810*    *12.7%*                    *Linear*                *0.55*   *4.3 \**        *2.7−5.9*       *2.2−6.4*
  *Lower Middle-Income*        *662*    *745*    *12.5%*                    *Linear*                *0.67*   *3.4 \**        *2.5−4.4*       *2.1−4.7*
  *Low-Income*                 *557*    *549*    *−1.5%*                    *Linear*                *0.06*   *−0.3*          *−0.8−0.2*      *−1.0−0.3*
  **Pediatric**                                                                                                                              
  Brazil                       468      505      7.8%                       Linear                  0.99     1.48 \*         1.42--1.54      1.40--1.57
  China                        467      613      31.4%                      Linear                  0.97     5.46 \*         5.04--5.87      4.90--6.02
  India                        519      713      37.3%                      Linear                  0.99     7.18 \*         6.92--7.43      6.83--7.52
  Russia                       636      658      3.6%                       Linear                  0.50     1.89 \*         1.13--2.66      0.86--2.93
  South Africa                 558      596      6.8%                       Logarithmic             0.06     −0.03           −1.19--1.12     −1.60--1.53
  *World*                      498      588      18.0%                      Linear                  0.99     3.5 \*          3.4−3.6         3.3−3.7
  *High-Income*                493      486      −1.5%                      Logarithmic             0.91     −0.2 \*         −0.3−(−0.2)     −0.3−(−0.1)
  *Upper Middle-Income*        505      594      17.7%                      Linear                  0.97     3.4 \*          3.2−3.6         3.1−3.7
  *Lower Middle-Income*        507      624      23.0%                      Linear                  0.99     4.6 \*          4.4−4.8         4.4−4.8
  *Low-Income*                 424      579      36.5%                      Linear                  0.97     6.4 \*          5.9−6.8         5.8−6.9
  **Neoplasm**                                                                                                                               
  Brazil                       38       75       99%                        Linear                  1        1.32 \*         1.30--1.35      1.29--1.36
  China                        47       136      189%                       Exponential             0.94     3.00 \*         2.51--3.49      2.34--3.66
  India                        22       34       58%                        Linear                  0.81     0.40 \*         0.32--0.47      0.29--0.05
  Russia                       106      174      64%                        Linear                  0.93     2.68 \*         2.38--2.98      2.27--3.08
  South Africa                 38       49       30%                        Logarithmic             0.39     0.28 \*\*       0.03--0.53      −0.06--0.62
  *World*                      *62*     *100*    *62.3%*                    *Linear*                *0.95*   *1.3 \**        *1.1−1.4*       *1.1−1.4*
  *High-Income*                *173*    *271*    *56.6%*                    *Linear*                *0.99*   *3.4 \**        *3.3−3.5*       *3.2−3.6*
  *Upper Middle-Income*        *50*     *115*    *130%*                     *Exponential*           *0.95*   *2.3 \**        *1.9−2.6*       *1.8−2.7*
  *Lower Middle-Income*        *27*     *38*     *40.1%*                    *Linear*                *0.76*   *0.4 \**        *0.3−0.5*       *0.3−0.5*
  *Low-Income*                 *27*     *26*     *−1.9%*                    *Linear*                *0.55*   *−0.1 \**       *−0.2−(−0.1)*   *−0.2−(−0.1)*
  **HIV-related**                                                                                                                            
  Brazil                       12.4     45.2     163%                       Linear                  0.94     1.1 \*          1.0--1.2        0.09--1.3
  China                        1.2      7.4      528%                       Linear                  0.98     0.2 \*          0.2--0.2        0.2--0.3
  India                        0.8      15.2     1905%                      Logarithmic             0.64     0.7 \*          0.3--1.0        0.2--1.1
  Russia                       4.5      61.7     1277%                      Exponential             1        1.8 \*          1.5--2.1        1.4--2.2
  South Africa                 17.3     1219     6469%                      Logarithmic             0.83     63.8 \*         51.0--76.5      46.5--81.0
  *World*                      *17*     *54*     *207%*                     *Logarithmic*           *0.79*   *1.28 \**       *0.79−1.77*     *0.62−1.94*
  *High-Income*                *14*     *19*     *37%*                      *Linear*                *0.04*   *0.04 \**       *−0.2−0.11*     *−0.6−0.13*
  *Upper Middle-Income*        *4*      *48*     *1255%*                    *Linear*                *0.89*   *1.89 \**       *1.62−2.15*     *1.53−2.24*
  *Lower Middle-Income*        *23*     *50*     *113%*                     *Logarithmic*           *0.71*   *1.39 \**       *0.85−1.93*     *0.66−2.12*
  *Low-Income*                 *160*    *178*    *12%*                      *Linear*                *0.09*   *−2.29*         *−5.15−0.58*    *−6.16−1.59*

Data obtained from: <http://ghdx.healthdata.org/gbd-results-tool>. Abbreviations: YLD--Year Lived with Disability. Legend: \* *p* \< 0.01; \*\* *p* \< 0.05. While possibly obtained through the same source, data for the global benchmarks, including computed values, were extracted from: Jesus TS, Landry MD, Brooks D, Hoenig H. Physical rehabilitation needs per condition type: Results from the Global Burden of Disease study 2017. Arch Phys Med Rehabill. doi: 10.1016/j.apmr.2019.12.020; Notes: The "*b* coefficient" refers to the annual change within a linear regression model. HIV/AIDs include YLDs from resultant tuberculosis.
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###### 

How YLD Rates (Years Lived with Disability per 100,000 people) likely benefiting from physical rehabilitation are distributed per major groups of conditions across the five countries analyzed, and how those percent values have evolved over time \[1990--2017\].

  --------------------------------------------------------------------------------------------------------------------------------------------------
                               \#\     \#\     \% Change\       Regression Model Type   r^2^   b Coefficient   95% CI             99% CI
                               1990    2017    \[1990--2017\]                                                                     
  ---------------------------- ------- ------- ---------------- ----------------------- ------ --------------- ------------------ ------------------
  **Musculoskeletal & Pain**                                                                                                      

  Brazil                       57.5%   59.9%   4.2%             Linear                  0.97   0.09 \*         0.09--0.10         0.09--0.10

  China                        49.4%   47.6%   −3.7%            Linear                  0.09   −0.03           −0.08--(−0.01)     −0.08--0.01

  India                        53.5%   51.3%   −4.0%            Linear                  0.91   −0.09           −0.10--(−0.08)     −0.10--(−0.07)

  Russia                       57.0%   53.7%   −5.7%            Linear                  0.67   −0.10           −0.13--(−0.07)     −0.14--(−0.06)

  South Africa                 47.2%   35.6%   −24.7%           Logarithmic             0.87   −0.54 \*        −0.66--(−0.41)     −0.70--(−0.37)

  World                        54.1%   52.6%   −2.8%            Linear                  0.87   −0.06 \*        −0.06−(−0.05)      −0.07−(−0.03)

  High--Income                 58.4%   57.7%   −1.2%            Linear                  0.72   −0.04 \*        −0.05−(−0.03)      −0.05−(−0.03)

  Upper Middle--Income         52.2%   50.7%   −2.8%            Linear                  0.29   −0.04 \*        −0.06−(−0.01)      −0.07−(−0.01)

  Lower Middle--Income         53.3%   52.1%   −2.3%            Linear                  0.97   −0.06 \*        −0.06−(−0.05)      −0.06−(−0.05)

  Low--Income                  49.9%   41.7%   −4.0%            Logarithmic             0.62   −0.06 \*        −0.09−(−0.02)      −0.11−(−0.01)

  **Neurological**                                                                                                                

  Brazil                       8.0%    9.3%    16.8%            Linear                  0.86   0.05 \*         0.04--0.06         0.04--0.06

  China                        12.3%   18.4%   49.2%            Exponential             0.96   0.19 \*         0.17--0.21         0.16--0.22

  India                        7.5%    8.1%    8.0%             Linear                  0.95   0.02 \*         0.02--0.03         0.02--0.03

  Russia                       16.1%   18.9%   17.6%            Linear                  0.74   0.10 \*         0.08--0.12         0.07--0.13

  South Africa                 9.7%    7.3%    −24.7%           Logarithmic             0.81   −0.12 \*        −0.15--(−0.09)     −0.16--(−0.08)

  World                        11.5%   12.9%   11.7%            Linear                  0.72   0.04 \*         0.03−0.05          0.03−0.05

  High--Income                 13.1%   14.0%   7.1%             Linear                  0.58   0.03 \*         0.02−0.04          0.02−0.04

  Upper Middle--Income         12.3%   15.8%   28.4%            Exponential             0.90   0.11 \*         0.10−0.13          0.10−0.13

  Lower Middle--Income         9.3%    9.6%    2.9%             Linear                  0.23   0.01 \*         0.002--0.02        0.002--0.02

  Low--Income                  10.8%   10.1%   −6.3%            Logarithmic             0.86   0.02 \*         −0.03−(−0.02)      −0.03−(−0.02)

  **Cardiothoracic**                                                                                                              

  Brazil                       18.9%   16.1%   −14.7%           Linear                  0.96   −0.10 \*        −0.11--(−0.09)     −0.11--(−0.09)

  China                        22.8%   18.1%   −20.8%           Logarithmic             0.71   −0.16 \*        −0.21--(−0.11)     −0.23--(−0.09)

  India                        22.6%   21.5%   −5.0%            Logarithmic             0.46   −0.04 \*\*      −0.07--(−0.01)     −0.07--0.002

  Russia                       14.0%   13.4%   −4.2%            Linear                  0.79   −0.04 \*        −0.04--(−0.03)     −0.05--(−0.03)

  South Africa                 25.0%   18.9%   −24.7%           Linear                  0.89   −0.30 \*        −0.34--(−0.26)     −0.36--(−0.24)

  World                        19.2%   18.0%   −6.2%            Logarithmic             0.57   −0.03 \*        −0.05−(−0.01)      −0.06−(−0.01)

  High--Income                 16.6%   16.6%   −0.1%            Linear                  0.56   0.03 \*         0.02−0.03          0.01−0.04

  Upper Middle--Income         20.0%   17.4%   −13.2%           Logarithmic             0.74   −0.09 \*        −0.12−(−0.06)      −0.13−(−0.05)

  Lower Middle--Income         20.5%   19.6%   −4.4%            Logarithmic             0.48   −0.02 \*\*      −0.04−(−0.005)     −0.05−0.002

  Low--Income                  18.7%   17.6%   −5.7%            Logarithmic             0.43   −0.02           −0.05−0.001        −0.06−0.01

  **Pediatric**                                                                                                                   

  Brazil                       14.2%   11.9%   −16.3%           Linear                  1      −0.09 \*        −0.09--(−0.09)     −0.09--(−0.09)

  China                        14.0%   12.9%   −7.8%            Linear                  0.39   −0.05 \*        −0.08--(−0.03)     −0.09--(−0.02)

  India                        15.7%   17.9%   13.6%            Linear                  0.84   0.08 \*         0.07--0.10         0.06--0.10

  Russia                       11.1%   10.3%   −7.0%            Logarithmic             0.92   −0.02 \*        −0.09--(−0.09)     −0.09--(−0.09)

  South Africa                 16.4%   12.3%   −25.5%           Logarithmic             0.80   −0.23 \*        −0.29--(−0.16)     −0.31--(−0.14)

  World                        13.0%   13.1%   0.6%             Logarithmic             0.15   0.003           −0.004−0.011       −0.007−0.013

  High--Income                 8.6%    7.3%    −14.8%           Linear                  0.99   −0.05 \*        −0.048−(−0.045)    −0.048−(−0.044)

  Upper Middle--Income         14.0%   12.7%   −9.4%            Linear                  0.73   −0.06 \*        −0.073−(−0.044)    −0.078−(−0.039)

  Lower Middle--Income         15.7%   16.4%   4.5%             Logarithmic             0.74   0.03 \*         0.023−0.042        0.020−0.045

  Low--Income                  14.2%   18.6%   30.6%            Linear                  0.92   0.19 \*         0.171−0.216        0.163−0.224

  **Neoplasms**                                                                                                                   

  Brazil                       1.14%   1.75%   54%              Linear                  0.98   0.021 \*        0.020--0.022       0.019--0.022

  China                        1.41%   2.86%   103%             Exponential             0.91   0.048 \*        0.040--0.056       0.037--0.059

  India                        0.66%   0.86%   30%              Linear                  0.71   0.006 \*        0.004--0.007       0.004--0.008

  Russia                       1.84%   2.72%   47%              Linear                  0.87   0.032 \*        0.027--0.032       0.025--0.039

  South Africa                 1.10%   1.00%   −10%             Linear                  0.56   −0.011 \*       −0.015--(−0.007)   −0.016--(−0.006)

  World                        1.6%    2.2%    38.3%            Linear                  0.94   0.02 \*         0.02−0.02          0.02−0.02

  High--Income                 3.0%    4.1%    35.5%            Logarithmic             0.97   0.04 \*         0.03−0.04          0.03−0.04

  Upper Middle--Income         1.4%    2.5%    77.0%            Exponential             0.92   0.04 \*         0.03−0.04          0.03−0.04

  Lower Middle--Income         0.8%    1.0%    19.0%            Linear                  0.53   0.01 \*         0.004−0.01         0.003−0.01

  Low--Income                  0.9%    0.8%    −6.1%            Linear                  0.59   −0.01 \*        −0.01−(−0.004)     −0.01−(−0.003)

  **HIV--related**                                                                                                                

  Brazil                       0.38%   1.06%   182%             Linear                  0.89   0.022 \*        0.019--0.025       0.018--0.027

  China                        0.04%   0.16%   341%             Linear                  0.99   0.005 \*        0.005--0.005       0.004--0.005

  India                        0.02%   0.38%   1558%            Linear                  0.55   0.016 \*        0.006--0.026       0.003--0.030

  Russia                       0.08%   0.97%   1137%            Exponential             1      0.028 \*        0.024--0.033       0.023--0.034

  South Africa                 0.51%   25.0%   4831%            Logarithmic             0.85   1.193 \*        0.939--1.448       0.849--1.538

  World                        0.5%    1.2%    162%             Linear                  0.89   0.02 \*         0.012−0.037        0.007−0.042

  High--Income                 0.2%    0.3%    19%              Linear                  0.99   0.001           −0.002−0.001       −0.003−0.001

  Upper Middle--Income         0.1%    1.0%    943%             Logarithmic             0.55   0.04 \*         0.032−0.048        0.029−0.050

  Lower Middle--Income         0.7%    1.3%    81%              Exponential             1.0    0.03 \*         0.016−0.050        0.010−0.056

  Low--Income                  5.4%    5.7%    7%               Logarithmic             0.85   −0.08           −0.166−0.009       −0.197−0.040
  --------------------------------------------------------------------------------------------------------------------------------------------------

Data obtained from: <http://ghdx.healthdata.org/gbd-results-tool>. Abbreviations: YLD--Year Lived with Disability. Legend: \* *p* \< 0.01; \*\* *p* \< 0.05. While possibly obtained through the same source, data for the global benchmarks, including computed values, were extracted from: Jesus TS, Landry MD, Brooks D, Hoenig H. Physical rehabilitation needs per condition type: Results from the Global Burden of Disease study 2017. Arch Phys Med Rehabill. doi: 10.1016/j.apmr.2019.12.020; Notes: Notes: The "b coefficient" refers to the annual change within a linear regression model and is set in percent values. Different population structures apply to countries with varying income levels; so, cross-location comparisons are not valid for the metric YLD Counts.
